Research

Tafalgie Therapeutics expands R&D capabilities and moves into new premises Tafalgie Therapeutics, a biopharmaceutical research company specialised in the development of treatments capable of relieving and preventing the onset of acute and chronic pain (inflammatory, post-operative, neuropathic) without side effects, announces that its teams are moving today to its new site in Luminy, Marseille, France, […]

Lire la suite

Aziz Moqrich has been awarded the SATT IMPACT 2022 Prize for his team’s work on the TAFA4 Protein Aziz Moqrich has been awarded the SATT IMPACT 2022 prize for his team’s work on the TAFA4 protein. Dr Moqrich is a Research Director at the IBDM laboratory (part of CNRS, the French Centre National de la […]

Lire la suite
Visit our contact page